SYMMETREL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Symmetrel, and what generic alternatives are available?
Symmetrel is a drug marketed by Endo Pharms and is included in three NDAs.
The generic ingredient in SYMMETREL is amantadine hydrochloride. There are seven drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the amantadine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Symmetrel
A generic version of SYMMETREL was approved as amantadine hydrochloride by UPSHER SMITH LABS on August 5th, 1986.
Summary for SYMMETREL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 154 |
| Clinical Trials: | 12 |
| Patent Applications: | 1,822 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | SYMMETREL at DailyMed |
Recent Clinical Trials for SYMMETREL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Columbia University | Phase 4 |
| Jon Rittenberger, MD | Phase 2 |
| American Heart Association | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for SYMMETREL
US Patents and Regulatory Information for SYMMETREL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Endo Pharms | SYMMETREL | amantadine hydrochloride | CAPSULE;ORAL | 016020-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Endo Pharms | SYMMETREL | amantadine hydrochloride | SYRUP;ORAL | 016023-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Endo Pharms | SYMMETREL | amantadine hydrochloride | TABLET;ORAL | 018101-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
